{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/measles/goals-outcome-measures/qipp-options-for-local-implementation/","result":{"pageContext":{"chapter":{"id":"e408b673-3cc9-556a-b3ad-7f2adc0c7e2f","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation","depth":2,"htmlHeader":"<!-- begin field b64b388b-357c-46ee-9f3d-57c5ff87a43f --><h2>QIPP - Options for local implementation</h2><!-- end field b64b388b-357c-46ee-9f3d-57c5ff87a43f -->","summary":null,"htmlStringContent":"<!-- begin item b34c068f-5f60-4f27-a4d7-edb1d72754b6 --><!-- begin field 95ad7f25-e90d-4140-a04f-52305b16f2bb --><ul><li><strong>Non-steroidal anti-inflammatory drugs (NSAIDs)</strong><ul><li>Review the appropriateness of nonsteroidal anti-inflammatory drug (NSAID) prescribing widely and on a routine basis, especially in people who are at higher risk of gastrointestinal, renal and cardiovascular morbidity and mortality (for example, older people).</li><li>If an NSAID is needed, use ibuprofen (1200 mg a day or less) or naproxen (1000 mg a day or less). Use the lowest effective dose and the shortest duration of treatment necessary to control symptoms.</li><li>Co-prescribe a proton pump inhibitor with NSAIDs for people who have osteoarthritis or rheumatoid arthritis, and think about the use of gastroprotective treatment when prescribing NSAIDs for low back pain.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/measles/references/\">NICE, 2017</a>] </p><!-- end field 95ad7f25-e90d-4140-a04f-52305b16f2bb --><!-- end item b34c068f-5f60-4f27-a4d7-edb1d72754b6 -->","topic":{"id":"0ec66249-42a4-5c0d-8a37-f2632ca7acde","topicId":"8b32d801-8035-4957-b21d-fdc0316b697d","topicName":"Measles","slug":"measles","lastRevised":"Last revised in March 2018","chapters":[{"id":"574596e7-391a-5ae2-bf0e-e7a3ac0db310","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"57c95110-4970-53c3-82ca-a0a02f782b1a","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"3968756f-72d2-5af8-a135-89adf3df1291","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"ef04938f-6cd8-5d2b-8031-e63619ffaae6","slug":"changes","fullItemName":"Changes"},{"id":"109f46c2-752c-5d34-a3a9-70f89ef6e6d8","slug":"update","fullItemName":"Update"}]},{"id":"0ac61cbb-f6a3-5cde-a49e-383cf998866c","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"af44849d-419b-5236-8667-1b06697011e9","slug":"goals","fullItemName":"Goals"},{"id":"8aa254cd-c0c4-5ad2-9778-896548b9ae3d","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"6e5a7bc2-88e4-5518-9a27-2c4cc8f96d43","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"e1e3d298-266c-53ca-a837-a43f7b51f000","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"e408b673-3cc9-556a-b3ad-7f2adc0c7e2f","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"4bbb33e5-786e-5140-803d-6c7d608ba7fd","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"25608b62-311c-5cfe-bf68-7953a8ee3737","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"da92a2f3-77ca-5048-8cae-2d7f1fbf552e","slug":"definition","fullItemName":"Definition"},{"id":"008ec2dd-b367-561a-8f55-c9d5ced49310","slug":"prevalence","fullItemName":"Prevalence"},{"id":"e8947faa-ab89-5369-a4ce-5d229aab4f40","slug":"complications","fullItemName":"Complications"},{"id":"c8086ee6-6b88-546f-9784-243317583284","slug":"prognosis","fullItemName":"Prognosis"},{"id":"f0a7fac1-bcd1-58ee-bd35-7c7cdd97c2b9","slug":"prevention","fullItemName":"Prevention"}]},{"id":"8a31ee21-9f32-5c22-955c-068539025090","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"258e5d5d-350e-51b5-b153-b71e658fa8b1","slug":"clinical-diagnosis","fullItemName":"Clinical diagnosis"},{"id":"60d5992e-b9ee-5ec0-8c37-2e09959645bf","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"42c95547-93f2-5eb8-a251-1331b9a2fae0","fullItemName":"Management","slug":"management","subChapters":[{"id":"daafe6b6-2230-5141-b9ba-d35b315dae91","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"652a2cc4-a89a-59a8-b1de-8e3927ccc932","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"1735c97d-c963-573a-b8b3-b03213e77a02","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"48a021d6-c031-58e0-9b01-8978137c72a8","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"c54e239c-eef4-5e71-9082-ef47671dd839","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"aaf0b0cb-35a7-52fb-96f9-e18ff97bd1b0","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"6248e49f-183f-5012-b8be-5fecfed55179","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"59da5ba6-9602-5e3c-9fa7-01b556316fbe","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"31dfda31-da84-5592-9695-d7dfc3dbdaee","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"0ac61cbb-f6a3-5cde-a49e-383cf998866c","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}